Glaxosmithkline’s Type 2 Diabetes Therapy Albiglutide Receives Positive Review from EU Committee The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing…
